4
Changes in Ownership
HANOVER INSURANCE GROUP, INC. Filed Acc 0001193125-26-459263
President and CEO sold 14,422 shares at an average $249.39 ($3,596,642)
- President and CEO gave up 60,198 shares (to pay taxes)
- President and CEO acquired 84,591 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Roche John C President and CEO | 2026-11-11 | Option exercise | +48,052 | $104.11 | $5,002,694 | 189,305.03 | D: show line 1 in the form |
| Roche John C President and CEO | 2026-11-11 | Option exercise | +36,539 | $117.22 | $4,283,102 | 225,844.03 | D: show line 2 in the form |
| Roche John C President and CEO | 2026-11-11 | Shares withheld for taxes | −60,198 | $248.53 | $14,961,009 | 165,646.03 | D: show line 3 in the form |
| Roche John C President and CEO | 2026-11-12 | Sale | −1,100 | $247.93 | $272,726 | 164,546.03 | D: show line 4 in the form |
| Roche John C President and CEO | 2026-11-12 | Sale | −10,393 | $249.37 | $2,591,674 | 154,153.03 | D: show line 5 in the form |
| Roche John C President and CEO | 2026-11-12 | Sale | −2,929 | $250.00 | $732,242 | 151,224.03 | D: show line 6 in the form |
| Open-market sales · 14,422 sh · avg $249.39 · $3,596,642 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Roche John C President and CEO | 2026-11-11 | Option exercise · Common Stock Option (right to buy) | −48,052 | 0 | D: show line 7 in the form | |||||
| Roche John C President and CEO | 2026-11-11 | Option exercise · Common Stock Option (right to buy) | −36,539 | 0 | D: show line 8 in the form |
Loading xslF345X06/ownership.xml…